T2
Device Trauma & Extremeties
PDI 04546540199324
General payments
$6,309,649
Research payments
$907,795
Through program year 2025, $6,309,649 in general payments and $907,795 in research payments were reported against T2 (Trauma & Extremeties).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $706,116 | 973 |
| 2025 | Research | $54,886 | 13 |
| 2024 | General | $945,237 | 1,516 |
| 2024 | Research | $136,994 | 28 |
| 2023 | General | $1,575,084 | 2,072 |
| 2023 | Research | $99,384 | 24 |
| 2022 | General | $1,756,038 | 3,198 |
| 2022 | Research | $273,715 | 34 |
| 2021 | General | $1,327,173 | 2,734 |
| 2021 | Research | $342,816 | 39 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 32 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 41 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
10,493 general · 138 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.